Soleno Therapeutics(SLNO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SLNO Soleno Therapeutics

盘前交易 04-01 07:43:11 EDT

33.48

+3.04

+9.99%

盘前35.33

+1.85+5.53%

07:42 EDT

最高34.88	最低30.90	成交量305.69万
今开30.90	昨收30.44	日振幅13.06%
总市值17.28亿	流通市值15.02亿	总股本5,162万
成交额1.03亿	换手率6.81%	流通股本4,487万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"SLNO","market":"US","secType":"STK","nameCN":"Soleno Therapeutics","latestPrice":33.48,"timestamp":1774987200000,"preClose":30.44,"halted":0,"volume":3056894,"hourTrading":{"tag":"盘前","latestPrice":35.33,"preClose":33.48,"latestTime":"07:42 EDT","volume":6665,"amount":234383.09623999998,"timestamp":1775043766101,"change":1.85,"changeRate":0.055257,"amplitude":0.01822},"delay":0,"changeRate":0.0998685939553218,"floatShares":44870900,"shares":51624384,"eps":0.39,"marketStatus":"盘前交易","change":3.04,"latestTime":"04-01 07:43:11 EDT","open":30.9,"high":34.875,"low":30.9,"amount":103170417.05151999,"amplitude":0.130585,"askPrice":35.34,"askSize":10,"bidPrice":34.99,"bidSize":19,"shortable":3,"etf":0,"ttmEps":0.39,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1775050200000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":33.48,"preHourTrading":{"tag":"盘前","latestPrice":35.33,"preClose":33.48,"latestTime":"07:42 EDT","volume":6665,"amount":234383.09623999998,"timestamp":1775043766101,"change":1.85,"changeRate":0.055257,"amplitude":0.01822},"postHourTrading":{"tag":"盘后","latestPrice":34.552,"preClose":33.48,"latestTime":"19:53 EDT","volume":24469,"amount":823746.5089,"timestamp":1775001192613,"change":1.072,"changeRate":0.032019,"amplitude":0.036819},"volumeRatio":1.8273301469105463,"impliedVol":0.9817,"impliedVolPercentile":0.824},"requestUrl":"/m/hq/s/SLNO","defaultTab":"news","newsList":[{"id":"1181753293","title":"Soleno Therapeutics宣布James Mackaness荣退，任命Jennifer Fulk为新任首席财务官","url":"https://stock-news.laohu8.com/highlight/detail?id=1181753293","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1181753293?lang=zh_cn&edition=full","pubTime":"2026-02-26 21:05","pubTimestamp":1772111137,"startTime":"0","endTime":"0","summary":"Soleno Therapeutics（简称SLNO）近日宣布，公司首席财务官James Mackaness已正式退休。与此同时，Jennifer Fulk被任命为新任首席财务官，即刻接任相关职责。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SLNO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138248088","title":"Soleno Therapeutics任命Jennifer Fulk为首席财务官 2026年3月2日生效","url":"https://stock-news.laohu8.com/highlight/detail?id=1138248088","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1138248088?lang=zh_cn&edition=full","pubTime":"2026-02-26 19:12","pubTimestamp":1772104321,"startTime":"0","endTime":"0","summary":"生物制药公司Soleno Therapeutics近日宣布一项重要人事任命。根据2月25日提交至美国证券交易委员会（SEC）的文件显示，公司已正式任命Jennifer Fulk担任首席财务官（CFO）一职，该任命将于2026年3月2日正式生效。\n此次高管变动标志着Soleno Therapeutics在战略布局上的重要一步。Jennifer Fulk在财务管理领域拥有丰富经验，预计将为公司带来新的发展动能。随着新任首席财务官的到位，Soleno Therapeutics有望进一步加强其财务运营体系，为未来业务拓展提供有力支撑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SLNO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128132855","title":"财报前瞻 ｜Soleno Therapeutics营收预计8,854.76万美元，机构观点偏看多","url":"https://stock-news.laohu8.com/highlight/detail?id=1128132855","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1128132855?lang=zh_cn&edition=full","pubTime":"2026-02-18 13:06","pubTimestamp":1771391219,"startTime":"0","endTime":"0","summary":"Soleno Therapeutics将于2026年02月25日盘后发布最新季度财报，市场关注营收动能与盈利质量的延续性及指引与一致预期的差异。市场一致预期本季度调整后每股收益为0.71，同比增长161.63%；息税前利润为3,641.53万美元，同比增长174.02%；营收预计为8,854.76万美元，目前缺少可靠同比口径，毛利率与净利率亦暂无覆盖的预测数据。公司上季度营收6,601.80万美元，毛利率98.27%，归属于母公司股东的净利润2,601.30万美元，净利率39.40%，调整后每股收益0.47，同比增长125.68%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻 ｜Soleno Therapeutics营收预计8,854.76万美元，机构观点偏看多","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLNO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183801152","title":"异动解读 | Soleno Therapeutics盘中大跌5.06%，因贝尔德下调目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1183801152","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1183801152?lang=zh_cn&edition=full","pubTime":"2026-01-13 23:18","pubTimestamp":1768317517,"startTime":"0","endTime":"0","summary":"Soleno Therapeutics（股票代码：SLNO）今日盘中股价大跌5.06%，引起市场关注。消息面上，贝尔德（Baird）分析师将其目标价从121美元下调至107美元。这一调整可能反映了分析师对公司未来业绩或市场前景的谨慎态度，从而影响了投资者的信心，导致股价下跌。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["SLNO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108532687","title":"Soleno Therapeutics公司预计2025年第二季度起Vykat XR美国销售净收入将达1.89亿至1.91亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1108532687","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1108532687?lang=zh_cn&edition=full","pubTime":"2026-01-12 20:06","pubTimestamp":1768219605,"startTime":"0","endTime":"0","summary":"Soleno Therapeutics公司近日发布预测，其核心产品Vykat XR自2025年第二季度在美国市场上市后，全年净销售收入预计将落在1.89亿美元至1.91亿美元的区间内。这一业绩展望凸显了公司对该创新疗法商业前景的强劲信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SLNO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2602630313","title":"Soleno Therapeutics, Inc.盘中异动 股价大跌5.09%报43.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602630313","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602630313?lang=zh_cn&edition=full","pubTime":"2026-01-10 01:14","pubTimestamp":1767978845,"startTime":"0","endTime":"0","summary":"北京时间2026年01月10日01时14分，Soleno Therapeutics, Inc.股票出现异动，股价大幅跳水5.09%。Soleno Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.59%。其相关个股中，Novabay Pharmaceuticals, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Akoustis Technologies Inc涨幅较大，Aptevo Therapeutics Inc.、Pmgc Holdings Inc.、Ibio, Inc.较为活跃，换手率分别为630.77%、72.24%、44.53%，振幅较大的相关个股有Novabay Pharmaceuticals, Inc.、Akoustis Technologies Inc、Revolution Medicines Inc C/Wts 17/12/2026 ，振幅分别为50.74%、36.28%、35.11%。Soleno Therapeutics, Inc.公司简介：Soleno Therapeutics Inc 是一家生物制药公司，开发用于治疗罕见病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260110011405a7083391&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260110011405a7083391&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SLNO","LENZ","BK4007","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147237720","title":"新闻稿：Soleno Therapeutics宣布董事会成员William G. Harris的去世","url":"https://stock-news.laohu8.com/highlight/detail?id=1147237720","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1147237720?lang=zh_cn&edition=full","pubTime":"2025-12-04 05:08","pubTimestamp":1764796080,"startTime":"0","endTime":"0","summary":"加州红木城，2025年12月3日— Soleno Therapeutics, Inc.是一家专注于开发治疗罕见疾病的新型药物的生物制药公司，今天遗憾地宣布，自2014年6月以来担任董事会重要成员的William G. \"Bill\" Harris已去世。“我认识Bill很多年，一直视他为一个具有正直品质的人，具备务实精神和真正帮助他人的愿望，” Soleno Therapeutics的首席执行官兼董事会主席Anish Bhatnagar博士表示。Soleno预计长期担任董事会及审计委员会成员的Andrew Sinclair将接任审计委员会主席一职。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TM","03160","BK4099","BK4604","BK4585","BK4588","BK4139","SLNO","BK4555"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123133830","title":"Soleno Therapeutics宣布进入1亿美元的加速回购协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1123133830","media":"投资观察","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1123133830?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:22","pubTimestamp":1763572953,"startTime":"0","endTime":"0","summary":"11月11日 - Soleno Therapeutics Inc宣布已签署一项1亿美元的加速回购协议。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SLNO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162270798","title":"Soleno Therapeutics股价在盘前上涨8.4%，因公司宣布进入1亿加元的加速股票回购协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1162270798","media":"美股速递","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162270798?lang=zh_cn&edition=full","pubTime":"2025-11-11 21:10","pubTimestamp":1762866612,"startTime":"0","endTime":"0","summary":"Soleno Therapeutics股价在盘前上涨8.4%，因公司宣布进入1亿加元的加速股票回购协议。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLNO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159294350","title":"Soleno Therapeutics公布2025年第三季度财务业绩，并提供Vykat(Tm) XR在美国上市的最新进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1159294350","media":"美股速递","labels":["productRelease","dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159294350?lang=zh_cn&edition=full","pubTime":"2025-11-05 05:02","pubTimestamp":1762290133,"startTime":"0","endTime":"0","summary":"Soleno Therapeutics公布2025年第三季度财务业绩，并提供Vykat(Tm) XR在美国上市的最新进展","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLNO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140636032","title":"Soleno Therapeutics任命生物制药高管Mark W. Hahn为董事会成员","url":"https://stock-news.laohu8.com/highlight/detail?id=1140636032","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1140636032?lang=zh_cn&edition=full","pubTime":"2025-10-13 20:03","pubTimestamp":1760357005,"startTime":"0","endTime":"0","summary":"加利福尼亚州红木城，2025年10月13日——专注于开发罕见病创新疗法的生物制药公司Soleno Therapeutics, Inc.宣布，任命生物制药金融资深人士Mark W. Hahn为独立董事，并担任审计委员会成员。Hahn先生为Soleno Therapeutics董事会带来了近30年首席财务官级别的丰富经验，在生命科学领域的多个成功产品上市、融资和并购交易中发挥了重要作用。随着Hahn先生的加入，Soleno Therapeutics董事会席位增至七个。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4585","BK4139","PWS","SLNO","TM","03160","BK4099","BK4604","BK4555"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518440852","title":"Soleno Therapeutics, Inc.2024财年实现净利润-1.76亿美元，同比减少351.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518440852","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518440852?lang=zh_cn&edition=full","pubTime":"2025-03-09 00:00","pubTimestamp":1741449624,"startTime":"0","endTime":"0","summary":"3月9日，Soleno Therapeutics, Inc.公布财报，公告显示公司2024财年净利润为-1.76亿美元，同比减少351.40%；其中营业收入为0.00美元，每股基本收益为-4.38美元。从资产负债表来看，Soleno Therapeutics, Inc.总负债85.86百万美元，其中短期债务526000.00美元，资产负债比为0.04，流动比率为0.16。机构评级：截至2025年3月9日，当前有9家机构对Soleno Therapeutics, Inc.目标价做出预测，其中目标均价为74.22美元，其中最低目标价为67.00美元，最高目标价为93.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000048a266b2e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000048a266b2e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SLNO","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517940492","title":"Stifel：重申Soleno Therapeutics(SLNO.US)买入评级, 目标价74.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517940492","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517940492?lang=zh_cn&edition=full","pubTime":"2025-03-06 02:01","pubTimestamp":1741197678,"startTime":"0","endTime":"0","summary":"Stifel：重申Soleno Therapeutics(SLNO.US)买入评级, 目标价74.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/06020148550853.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","SLNO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517606088","title":"Soleno Therapeutics, Inc.盘中异动 早盘快速下跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517606088","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517606088?lang=zh_cn&edition=full","pubTime":"2025-03-05 00:20","pubTimestamp":1741105248,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日00时20分，Soleno Therapeutics, Inc.股票出现异动，股价急速下跌5.07%。Soleno Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.35%。其相关个股中，Cyclacel Pharmaceuticals Inc 6% Cnv Pfd Usd、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Protagenic Therapeutics, Inc.涨幅较大，Aeon Biopharma, Inc.、Windtree Therapeutics, Inc.、Protagenic Therapeutics, Inc.较为活跃，换手率分别为1194.86%、1163.78%、787.57%，振幅较大的相关个股有Cyclacel Pharmaceuticals Inc 6% Cnv Pfd Usd、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Celularity Inc C/Wts 16/07/2026 ，振幅分别为117.24%、66.67%、66.02%。Soleno Therapeutics, Inc.公司简介：Soleno Therapeutics Inc致力于治疗罕见病的新型疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305002048989bc7fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305002048989bc7fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SLNO","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516580646","title":"Soleno Therapeutics, Inc.盘中异动 早盘快速跳水5.28%报46.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516580646","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516580646?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:56","pubTimestamp":1741017398,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时56分，Soleno Therapeutics, Inc.股票出现异动，股价急速跳水5.28%。Soleno Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.38%。其相关个股中，Bioxcel Therapeutics, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Entero Therapeutics Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为2962.91%、142.08%、134.38%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Pliant Therapeutics, Inc.，振幅分别为206.20%、70.53%、50.09%。Soleno Therapeutics, Inc.公司简介：Soleno Therapeutics Inc致力于治疗罕见病的新型疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303235638a25d5b20&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303235638a25d5b20&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","SLNO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516379822","title":"Soleno Therapeutics, Inc.盘中异动 急速拉升5.45%报47.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516379822","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516379822?lang=zh_cn&edition=full","pubTime":"2025-03-01 00:05","pubTimestamp":1740758745,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日00时05分，Soleno Therapeutics, Inc.股票出现异动，股价快速拉升5.45%。Soleno Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。其相关个股中，Bioxcel Therapeutics, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Enveric Biosciences, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Enveric Biosciences, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为2138.83%、472.62%、355.99%，振幅较大的相关个股有Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Bioxcel Therapeutics, Inc.，振幅分别为46.60%、43.95%、41.62%。Soleno Therapeutics, Inc.公司简介：Soleno Therapeutics Inc致力于治疗罕见病的新型疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030100054596342e42&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030100054596342e42&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","SLNO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514543963","title":"Soleno Therapeutics(SLNO.US)：2024年Q4财报实现营收0美元，前值为0美元；每股收益为-1.27美元，前值为-0.33美元，预期值为-0.64美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514543963","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514543963?lang=zh_cn&edition=full","pubTime":"2025-02-28 07:08","pubTimestamp":1740697723,"startTime":"0","endTime":"0","summary":"Soleno Therapeutics(SLNO.US)：2024年Q4财报实现营收0美元，前值为0美元；每股收益为-1.27美元，前值为-0.33美元，预期值为-0.64美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/28070848442549.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","SLNO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105884826","title":"Soleno Therapeutics 2024年第四季度GAAP每股收益$(1.27)，低于预期$(0.94)","url":"https://stock-news.laohu8.com/highlight/detail?id=1105884826","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1105884826?lang=zh_cn&edition=full","pubTime":"2025-02-28 05:46","pubTimestamp":1740692798,"startTime":"0","endTime":"0","summary":"$Soleno Therapeutics$  公布的季度每股亏损为$，低于分析师共识预期的$，比预期低35.11%。这比去年同期每股亏损$减少了284.85%。以上内容来自Benzinga Earnings专栏，原文如下：$Soleno Therapeutics$  reported quarterly losses of $ per share which missed the analyst consensus estimate of $ by 35.11 percent. This is a 284.85 percent decrease over losses of $ per share from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Soleno Therapeutics 2024年第四季度GAAP每股收益$(1.27)，低于预期$(0.94)","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLNO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514856477","title":"Soleno Therapeutics, Inc.盘中异动 大幅拉升5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514856477","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514856477?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:33","pubTimestamp":1740580433,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时33分，Soleno Therapeutics, Inc.股票出现异动，股价快速上涨5.28%。Soleno Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。其相关个股中，Immunoprecise Antibodies Ltd.、Channel Therapeutics Corporation、Alpha Tau Medical Ltd C/Wts 涨幅较大，Organovo Holdings, Inc.、Cns Pharmaceuticals, Inc.、Immunoprecise Antibodies Ltd.较为活跃，换手率分别为124.33%、93.06%、75.02%，振幅较大的相关个股有Nutriband Inc C/Wts 、Channel Therapeutics Corporation、Aspire Biopharma Holdings, Inc.，振幅分别为17.13%、16.86%、15.98%。Soleno Therapeutics, Inc.公司简介：Soleno Therapeutics Inc致力于治疗罕见病的新型疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223353a254f723&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223353a254f723&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SLNO","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511612933","title":"Soleno Therapeutics, Inc.盘中异动 临近收盘快速下跌5.02%报48.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511612933","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511612933?lang=zh_cn&edition=full","pubTime":"2025-02-15 04:38","pubTimestamp":1739565538,"startTime":"0","endTime":"0","summary":"北京时间2025年02月15日04时38分，Soleno Therapeutics, Inc.股票出现波动，股价大幅跳水5.02%。Soleno Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.71%。其相关个股中，Moleculin Biotech, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Allogene Therapeutics, Inc.涨幅较大，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为3198.28%、823.90%、639.25%，振幅较大的相关个股有Abpro Holdings Inc C/Wts 12/11/2029 、Lexaria Bioscience Corp C/Wts 14/01/2026 、Moleculin Biotech, Inc.，振幅分别为83.06%、74.35%、71.65%。Soleno Therapeutics, Inc.公司简介：Soleno Therapeutics Inc致力于治疗罕见病的新型疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502150438589885d98a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502150438589885d98a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","SLNO"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.soleno.life","stockEarnings":[{"period":"1week","weight":0.0683},{"period":"1month","weight":-0.1431},{"period":"3month","weight":-0.2769},{"period":"6month","weight":-0.4226},{"period":"1year","weight":-0.5314},{"period":"ytd","weight":-0.2769}],"compareEarnings":[{"period":"1week","weight":-0.0043},{"period":"1month","weight":-0.052},{"period":"3month","weight":-0.0463},{"period":"6month","weight":-0.0282},{"period":"1year","weight":0.1626},{"period":"ytd","weight":-0.0463}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Soleno Therapeutics, Inc.于1999年8月25日在特拉华州成立。该公司专注于治疗罕见病的新型疗法的开发和商业化。该公司的主要候选药物DCCR（二氮嗪胆碱）缓释片是一种有效的ATP敏感钾（KATP）通道激活剂。","yearOnYearQuotes":[{"month":1,"riseRate":0.583333,"avgChangeRate":0.026118},{"month":2,"riseRate":0.333333,"avgChangeRate":0.234502},{"month":3,"riseRate":0.583333,"avgChangeRate":-0.004811},{"month":4,"riseRate":0.454545,"avgChangeRate":0.050237},{"month":5,"riseRate":0.545455,"avgChangeRate":0.074125},{"month":6,"riseRate":0.363636,"avgChangeRate":-0.071619},{"month":7,"riseRate":0.363636,"avgChangeRate":-0.051924},{"month":8,"riseRate":0.545455,"avgChangeRate":-0.014863},{"month":9,"riseRate":0.454545,"avgChangeRate":0.409781},{"month":10,"riseRate":0.272727,"avgChangeRate":-0.115533},{"month":11,"riseRate":0.454545,"avgChangeRate":-0.012609},{"month":12,"riseRate":0.333333,"avgChangeRate":0.051862}],"exchange":"NASDAQ","name":"Soleno Therapeutics","nameEN":"Soleno Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Soleno Therapeutics(SLNO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Soleno Therapeutics(SLNO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Soleno Therapeutics,SLNO,Soleno Therapeutics股票,Soleno Therapeutics股票老虎,Soleno Therapeutics股票老虎国际,Soleno Therapeutics行情,Soleno Therapeutics股票行情,Soleno Therapeutics股价,Soleno Therapeutics股市,Soleno Therapeutics股票价格,Soleno Therapeutics股票交易,Soleno Therapeutics股票购买,Soleno Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Soleno Therapeutics(SLNO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Soleno Therapeutics(SLNO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}